Clinical Trial Update: ⁶⁸Ga-DPA in the Lung Cancer Diagnosis [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial is evaluating 68Ga-DPA for diagnosis of lung cancer. The study is currently enrolling by invitation and is sponsored by Peking Union Medica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• 68Ga-DPA

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Lung Cancers | EARLY_Phase 1 | Status: ENROLLING_BY_INVITATION